Effects of MEDI0382 on Pancreatic and Incretin Hormones

被引：0
|
作者：
Parker, Victoria E. R.
Tsai, Lan-Feng
Robertson, Darren
Petrone, Marcella
Rondinone, Cristina
Hirshberg, Boaz
Jermutus, Lutz
Ambery, Philip
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-79-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effects of MEDI0382, a glucagon-like peptide 1/glucagon receptor dual agonist, on pancreatic and incretin hormones
    Jermutus, L.
    Tsai, L. -F.
    Robertson, D.
    Petrone, M.
    Rondinone, C.
    Boaz, H.
    Ambery, P.
    Parker, V.
    DIABETOLOGIA, 2018, 61 : S382 - S382
  • [2] Effect of MEDI0382 on the Pharmacodynamics and Pharmacokinetics of Warfarin or Esmolol in Healthy Volunteers
    Coleman, Hugh A.
    Petrone, Marcella
    Petrohoy, Theresa M.
    Yang, Ye
    Sanford, Lindsay J.
    Hansen, Lars
    Flor, Armando
    DIABETES, 2019, 68
  • [3] Cotadutide (MEDI0382) promotes dose-dependent increases in gastric emptying time
    Robertson, D.
    Parker, V. E.
    Ambery, P. D.
    Petrone, M.
    Wang, T.
    Heise, T.
    Plum-Moerschel, L.
    Jermutus, L.
    Hirshberg, B.
    Meier, J. J.
    DIABETOLOGIA, 2019, 62 : S58 - S58
  • [4] MEDI0382, a GLP-1/glucagon receptor dual agonist, improves NASH and reduces liver fibrosis in mice
    Trevaskis, J. L.
    Boland, M. L.
    Conway, J.
    Guionaud, S.
    Grimsby, J.
    Jermutus, L.
    Rhodes, C. J.
    DIABETOLOGIA, 2018, 61 : S590 - S590
  • [5] A Phase 1, Open-Label, Single-Dose Study to Evaluate Pharmacokinetics of MEDI0382 in Patients with Renal Impairment
    Klein, Gernot K.
    Petrone, Marcella
    Yang, Ye
    Hoang, Thuong
    Dicostanza, Sheila
    Hansen, Lars
    Flor, Armando
    DIABETES, 2019, 68
  • [6] Effects of MEDI0382, an Oxyntomodulin-Like Peptide with Targeted GLP-1/Glucagon Receptor Activity, on Amino Acids, Ketones, and Free Fatty Acids
    Parker, Victoria E.
    Robertson, Darren
    Wang, Tao
    Hornigold, David C.
    Posch, Maximilian G.
    Plum-Moerschel, Leona
    Meier, Juris J.
    Schlichthaar, Heike
    Klaus, Beate M.
    Jermutus, Lutz
    Ambery, Philip
    Hirshberg, Boaz
    DIABETES, 2019, 68
  • [7] Evaluating the Sub-chronic Effects of MEDI0382, a GLP-1/Glucagon Receptor Dual Agonist, on Weight Loss in Male ob/ob Mice
    Oldham, Stephanie
    Church, Christopher D.
    Will, Sarah
    Konkar, Anish
    Trevaskis, James
    Davies, Graeme R.
    DIABETES, 2018, 67
  • [8] MEDI0382, a GLP-1/Glucagon Receptor Dual Agonist, Dramatically Reduces Hepatic Collagen in a Mouse Model of NASH
    Beaton, Michelle
    Guionaud, Silvia
    Conway, James P.
    Grimsby, Joe
    Rhodes, Christopher J.
    Jermutus, Lutz
    Trevaskis, James
    DIABETES, 2019, 68
  • [9] MEDI0382, a GLP-1/Glucagon Receptor Dual Agonist, Dramatically Reduces Hepatic Collagen in a Mouse Model of NASH
    Beaton, Michelle
    Guionaud, Silvia
    Conway, James P.
    Grimsby, Joe
    Rhodes, Christopher J.
    Jermutus, Lutz
    Trevaskis, James
    DIABETES, 2018, 67
  • [10] MEDI0382, a GLP/Glucagon Receptor Dual Agonist, Significantly Reduces Hepatic Fat Content in Subjects with Type 2 Diabetes Mellitus
    Jain, Meena
    Tsai, Lan-Feng
    Robertson, Darren
    Hirshberg, Boaz
    Hockings, Paul
    Johansson, Lars
    Ambery, Philip
    DIABETES, 2018, 67
12345